Startseite Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome

  • Loredan Stefan Niculescu , Jamila Fruchart-Najib , Jean-Charles Fruchart und Anca Sima
Veröffentlicht/Copyright: 11. September 2007
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 45 Heft 9

Abstract

Background: Genetic variation at the apolipoprotein A-V locus, recently discovered proximal to the APOA1/C3/A4 gene cluster, is associated with elevated triglyceride concentrations, a risk factor for atherosclerosis.

Methods: The goal of our study was to determine the association of two apolipoprotein A-V (APOA5) gene polymorphisms in a group of urban Romanian subjects with the prevalence of the metabolic syndrome. For this purpose, we assayed −1.131T>C and c.56C>G polymorphisms for 279 subjects divided into three groups: a control group, a metabolic syndrome group and a cardiovascular disease group. Then we correlated the minor allele frequencies with body mass index and biochemical parameters.

Results: We obtained higher frequency for −1.131C compared to c.56G alleles, both mainly distributed in overweight subjects. Body mass index and triglyceride levels were higher in −1.131C allele carriers in metabolic syndrome patients, but were not significantly different in c.56G carriers compared to those with the native gene. Metabolic syndrome −1.131C homozygotes presented lower high-density lipoprotein cholesterol and higher glucose levels compared to subjects with the native gene. Total cholesterol, low-density lipoprotein cholesterol and insulin were not different between −1.131C or c.56G allele carriers and those with the native gene.

Conclusions: Our results demonstrate an independent risk for −1.131T>C APOA5 gene polymorphisms in the development of metabolic syndrome.

Clin Chem Lab Med 2007;45:1133–9.


Corresponding author: Loredan Stefan Niculescu, Department of Lipoproteins and Atherosclerosis, Institute of Cellular Biology and Pathology “Nicolae Simionescu”, 8 B.P. Hasdeu Street, P.O. Box 35-14, Bucharest 050568, Romania Phone +40-21-3194518, Fax +40-21-3194519,

Received: 2006-11-6
Accepted: 2007-4-5
Published Online: 2007-09-11
Published in Print: 2007-09-01

©2007 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. SIBioC 2007, 39th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Palacongressi Rimini (Italy), 2-5 October 2007
  2. Third “Biologie Prospective” Santorini Conference
  3. Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease
  4. Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients
  5. Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)
  6. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
  7. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
  8. Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
  9. Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
  10. Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems
  11. New perspectives and strategy research biomarkers for hepatocellular carcinoma
  12. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review
  13. The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
  14. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
  15. Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
  16. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
  17. Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
  18. The association between lipid profiles and breast cancer among Taiwanese women
  19. Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
  20. Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
  21. Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
  22. Intra-individual variation in creatinine and cystatin C
  23. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention
  24. An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination
  25. Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting
  26. Type B natriuretic peptide stability in frozen plasma
Heruntergeladen am 11.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.257/html
Button zum nach oben scrollen